BioSpace News Archive

Forbion announces that it has participated in a £100 million Series B financing of Achilles Therapeutics, a biopharmaceutical company developing personalised cancer immunotherapies.

TrialScope has released a new version of its TrialScope DiscloseTM platform, featuring a revamped user interface (UI).

True Diagnostics, Inc. and Veravas announced their Strategic Alliance in the commercialization of VeraTest Biotin, a portable and easy-to-use digital qualitative test that can rapidly screen patient samples to determine if significant biotin is present, helping safeguard against potential biotin interference.

$7.2 million total funding since 2015 for more providers of age-friendly healthcare

Atriva Therapeutics GmbH announced its participation in four upcoming partnering conferences worldwide.

Total GIP NL-ELISA for specific determination of glucose-dependent insulinotropic peptide in human samples

A fully integrated biopharmaceutical company - Uni-Bio Science Group Limited are pleased to announce that its interim results for the period ended 30 June 2019

Financial terms of the collaboration were not disclosed but shareholders of the Pennsylvania-based company responded favorably.

Hutchison China MediTech Limited has initiated an international Phase I/Ib study of HMPL-689, its novel, highly selective and potent small molecule phosphoinositide-3 kinase delta isoform inhibitor, in patients with relapsed or refractory lymphoma.

Having been dedicated to the great cause of supplying peptides for nearly two decades, the New York-based brand Creative Peptides recently adds another major peptide category for scientists who are involved with cardiovascular disease research.